All eyes on Springer’s €2.5bn cov-lite loan

A €2.5bn-equivalent cov-lite loan backing the €3.3bn acquisition of German publisher Springer Science by private equity firm BC Partners should prove no challenge for European investors, according to leveraged loan bankers.

  • By Olivier Holmey
  • 20 Jun 2013
Leads have said this deal would be the largest cov-lite loan marketed in Europe so far. Although it will contain a dollar-denominated tranche, banks involved expect the deal's euro portion to be far larger than previous such tranches, including the €450m tranche that formed part of the refinancing ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Share % by Volume
1 Societe Generale 15.35
2 Rabobank 14.41
3 Morgan Stanley 11.73
4 Barclays 8.99
5 Credit Agricole 7.57

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 27 Feb 2017
1 Wells Fargo Securities 11,897.40 33 11.83%
2 Bank of America Merrill Lynch 9,837.56 29 9.78%
3 Citi 9,714.54 32 9.66%
4 JPMorgan 7,997.38 24 7.95%
5 Credit Suisse 6,335.67 14 6.30%